Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kestra Medical Technologies (KMTS) Gross Margin (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Gross Margin for 3 consecutive years, with 52.57% as the latest value for Q1 2026.

  • Quarterly Gross Margin rose 918.0% to 52.57% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 48.75% through Jan 2026, up 1460.0% year-over-year, with the annual reading at 40.47% for FY2025, 3917.0% up from the prior year.
  • Gross Margin for Q1 2026 was 52.57% at Kestra Medical Technologies, up from 50.63% in the prior quarter.
  • The five-year high for Gross Margin was 52.57% in Q1 2026, with the low at 10.63% in Q1 2024.
  • Average Gross Margin over 3 years is 37.06%, with a median of 43.39% recorded in 2025.
  • The sharpest move saw Gross Margin surged 3275bps in 2025, then skyrocketed 918bps in 2026.
  • Over 3 years, Gross Margin stood at 39.63% in 2024, then rose by 28bps to 50.63% in 2025, then increased by 4bps to 52.57% in 2026.
  • According to Business Quant data, Gross Margin over the past three periods came in at 52.57%, 50.63%, and 45.69% for Q1 2026, Q4 2025, and Q3 2025 respectively.